Candidate gene association study for diabetic retinopathy in Chinese patients with type 2 diabetes

Molecular Vision

Volumn 20, Issue , 2014, Pages 200-214

  Yang, Xiu Fen ^a,b   Deng, Yu ^a,c   Gu, Hong ^a   Ren, Xue Tao ^a,d   Li, Na ^a   Lim, Apiradee ^e   Snellingen, Torkel ^d   Liu, Xi Pu ^d   Wang, Ning Li ^a   Liu, Ning Pu ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c CAPITAL MEDICAL UNIVERSITY   (China)

^d Sekwa Institute of Medical Science   (China)

^e PRINCE OF SONGKLA UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE REDUCTASE; DIPEPTIDYL CARBOXYPEPTIDASE; ERYTHROPOIETIN; INTERCELLULAR ADHESION MOLECULE 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN KINASE C BETA; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2;

ACE GENE; ADULT; AKR1B1 GENE; ALLELE; ARTICLE; CASE CONTROL STUDY; CHINESE; COHORT ANALYSIS; CONTROLLED STUDY; DIABETIC RETINOPATHY; EPO GENE; FEMALE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPING TECHNIQUE; HAPLOTYPE; HUMAN; ICAM 1 GENE; KDR GENE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PKC BETA GENE; PPAR GAMMA GENE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; VEGF GENE;

ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; BIOLOGICAL MARKERS; CHINA; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; MULTIVARIATE ANALYSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 84896875014     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Cheung N, Mitchell P, Wong TY. Diabetic retinopathy. Lancet 2010; 376:124-36. [PMID: 20580421].
2. Matthews DR, Stratton IM, Aldington SJ, Holman RR, Kohner EM, Study PD. Risks of progression of retinopathy and vision loss related to tight blood pressure control in type 2 diabetes mellitus - UKPDS 69. Arch Ophthalmol-Chic 2004; 122:1631-40. [PMID: 15534123].
3. Stratton IM, Kohner EM, Aldington SJ, Turner RC, Holman RR, Manley SE, Matthews DR, Grp U. UKPDS 50: Risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis. Diabetologia 2001; 44:156-63. [PMID: 11270671].
4. Mohamed Q, Gillies MC, Wong TY. Management of diabetic retinopathy - A systematic review. JAMA 2007; 298:902-16. [PMID: 17712074].
5. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 1993; 329:977-86. [PMID: 8366922].
6. Sobrin L, Green T, Sim X, Jensen RA, Tai ES, Tay WT, Wang JJ, Mitchell P, Sandholm N, Liu Y, Hietala K, Iyengar SK, Brooks M, Buraczynska M, Van Zuydam N, Smith AV, Gudnason V, Doney AS, Morris AD, Leese GP, Palmer CN, Swaroop A, Taylor HA Jr, Wilson JG, Penman A, Chen CJ, Groop PH, Saw SM, Aung T, Klein BE, Rotter JI, Siscovick DS, Cotch MF, Klein R, Daly MJ, Wong TY. Candidate gene association study for diabetic retinopathy in persons with type 2 diabetes: the Candidate gene Association Resource (CARe). Invest Ophthalmol Vis Sci 2011; 52:7593-602. [PMID: 21873659].
7. Arar NH, Freedman BI, Adler SG, Iyengar SK, Chew EY, Davis MD, Satko SG, Bowden DW, Duggirala R, Elston RC, Guo X, Hanson RL, Igo RP, Ipp E, Kimmel PL, Knowler WC, Molineros J, Nelson RG, Pahl MV, Quade SRE, Rasooly RS, Rotter JI, Saad MF, Scavini M, Schelling JR, Sedor JR, Shah VO, Zager PG, Abboud HE, Diabet FIN. Heritability of the severity of diabetic retinopathy: The FIND-Eye study. Invest Ophthalmol Vis Sci 2008; 49:3839-45. [PMID: 18765632].
8. Hietala K, Forsblom C, Summanen P, Groop PH, Grp FS. Heritability of proliferative diabetic retinopathy. Diabetes 2008; 57:2176-80. [PMID: 18443200].
9. Huang YC, Tsai FJ, Lin JM, Lin HJ, Chen CC, Chen SY, Tsai CH. Genome-wide Association Study of Diabetic Retinopathy in a Taiwanese Population. Ophthalmology 2011; 118:642-8. [PMID: 21310492].
10. Paterson AD, Waggott D, Shen EQ, Boright AP, Hosseini M, Cleary PA, Lachin JM, Sun L, Bull S, Grp DER. Genome-Wide Association Study of Risk for Diabetic Retinopathy in Type 1 Diabetes. Diabetes 2010; 2010
11. Fu YP, Hallman DM, Gonzalez VH, Klein BE, Klein R, Hayes MG, Cox NJ, Bell GI, Hanis CL. Identification of Diabetic Retinopathy Genes through a Genome-Wide Association Study among Mexican-Americans from Starr County, Texas. J Ophthalmol 2010; 2010:[PMID: 20871662].
12. Hallman DM, Boerwinkle E, Gonzalez VH, Klein BE, Klein R, Hanis CL. A genome-wide linkage scan for diabetic retinopathy susceptibility genes in Mexican Americans with type 2 diabetes from Starr County, Texas. Diabetes 2007; 56:1167-73. [PMID: 17251272].
13. Imperatore G, Hanson RL, Pettitt DJ, Kobes S, Bennett PH, Knowler WC. Sib-pair linkage analysis for susceptibility genes for microvascular complications among Pima Indians with type 2 diabetes. Pima Diabetes Genes Group. Diabetes 1998; 47:821-30. [PMID: 9588456].
14. Looker HC, Nelson RG, Chew E, Klein R, Klein BE, Knowler WC, Hanson RL. Genome-wide linkage analyses to identify Loci for diabetic retinopathy. Diabetes 2007; 56:1160-6. [PMID: 17395753].
15. Malecki MT, Cyganek K, Mirkiewicz-Sieradzka B, Wolkow PP, Wanic K, Skupien J, Solnica B, Sieradzki J. Alanine variant of the Pro12Ala polymorphism of the PPARgamma gene might be associated with decreased risk of diabetic retinopathy in type 2 diabetes. Diabetes Res Clin Pract 2008; 80:139-45. [PMID: 18077048].
16. Yang X, Deng Y, Gu H, Lim A, Altankhuyag A, Jia W, Ma K, Xu J, Zou Y, Snellingen T, Liu X, Wang N, Liu N. Polymorphisms in the vascular endothelial growth factor gene and the risk of diabetic retinopathy in Chinese patients with type 2 diabetes. Mol Vis 2011; 17:3088-96. [PMID: 22162628].
17. Churchill AJ, Carter JG, Ramsden C, Turner SJ, Yeung A, Brenchley PEC, Ray DW. VEGF polymorphisms are associated with severity of diabetic retinopathy. Invest Ophthalmol Vis Sci 2008; 49:3611-6. [PMID: 18441306].
18. Al-Kateb H, Mirea L, Xie XL, Sun L, Liu M, Chen HT, Bull SB, Boright AP, Paterson AD, Group DER. Multiple variants in vascular endothelial growth factor (VEGFA) are risk factors for time to severe retinopathy in type 1 diabetes - The DCCT/EDIC genetics study. Diabetes 2007; 56:2161-8. [PMID: 17513698].
19. Nakanishi K, Watanabe C. Single nucleotide polymorphisms of vascular endothelial growth factor gene intron 2 are markers for early progression of diabetic retinopathy in Japanese with type 1 diabetes. Clin Chim Acta 2009; 402:171-5. [PMID: 19263526].
20. Tong Z, Yang ZL, Patel S, Chen HY, Gibbs D, Yang X, Hau VS, Kaminoh Y, Harmon J, Pearson E, Buehler J, Chen YH, Yu BF, Tinkham NH, Zabriskie NA, Zeng JX, Luo L, Sun JK, Prakash M, Hamam RN, Tonna S, Constantine R, Ronquillo CC, Sadda S, Avery RL, Brand JM, London N, Anduze AL, King GL, Bernstein PS, Watkins S, Jorde LB, Li DY, Aiello LP, Pollak MR, Zhang K, Genet D, Diabe Complicat S. Promoter polymorphism of the erythropoietin gene in severe diabetic eye and kidney complications. Proc Natl Acad Sci USA 2008; 105:6998-7003. [PMID: 18458324].
21. Abhary. Association Between Erythropoietin Gene Polymorphisms and Diabetic Retinopathy (vol 128, pg 102, 2010). Arch Ophthalmol 2010; 128:311.
22. Kao YL, Donaghue K, Chan A, Knight J, Silink M. A novel polymorphism in the aldose reductase gene promoter region is strongly associated with diabetic retinopathy in adolescents with type 1 diabetes. Diabetes 1999; 48:1338-40. [PMID: 10342825].
23. Olmos P, Futers S, Acosta AM, Siegel S, Maiz A, Schiaffino R, Morales P, Diaz R, Arriagada P, Claro JC, Vega R, Vollrath V, Velasco S, Emmerich M. (AC)(23) Z-2 polymorphism of the aldose reductase gene and fast progression of retinopathy in Chilean type 2 diabetics. Diabetes Res Clin Pract 2000; 47:169-76. [PMID: 10741565].
24. Richeti F, Noronha RM, Waetge RTL, de Vasconcellos JPC, de Souza OF, Kneipp B, Assis N, Rocha MN, Calliari LEP, Longui CA, Monte O, de Melo MB. Evaluation of AC(n) and C(-106)T polymorphisms of the aldose reductase gene in Brazilian patients with DM1 and susceptibility to diabetic retinopathy. Mol Vis 2007; 13:740-5.
25. Abhary S, Hewitt AW, Burdon KP, Craig JE. A Systematic Meta-Analysis of Genetic Association Studies for Diabetic Retinopathy. Diabetes 2009; 58:2137-47. [PMID: 19587357].
26. Uthra S, Raman R, Mukesh BN, Rajkumar SA, Kumari PR, Lakshmipathy P, Gnanamoorthy P, Sharma T, McCarty CA, Kumaramanickavel G. Protein kinase C beta (PRKCB1) and pigment epithelium derived factor (PEDF) gene polymorphisms and diabetic retinopathy in a south Indian cohort. Ophthalmic Genet 2010; 31:18-23. [PMID: 20141354].
27. Ikeda Y, Suehiro T, Osaki F, Tsuzura S, Kumon Y, Hashimoto K. Polymorphisms in the 5 '-upstream region of the PKC beta gene in Japanese patients with Type 2 diabetes. Diabet Med 2004; 21:1113-20. [PMID: 15384959].
28. Matsumoto A, Iwashima Y, Abiko A, Morikawa A, Sekiguchi M, Eto M, Makino I. Detection of the association between a deletion polymorphism in the gene encoding angiotensin I-converting enzyme and advanced diabetic retinopathy. Diabetes Res Clin Pract 2000; 50:195-202. [PMID: 11106834].
29. Kamiuchi K, Hasegawa G, Obayashi H, Kitamura A, Ishii M, Yano M, Kanatsuna T, Yoshikawa T, Nakamura N. Intercellular adhesion molecule-1 (ICAM-1) polymorphism is associated with diabetic retinopathy in Type 2 diabetes mellitus. Diabet Med 2002; 19:371-6. [PMID: 12027924].
30. Liu L, Yu Q, Wang H, Zhang SX, Huang C, Chen X. Association of intercellular adhesion molecule 1 polymorphisms with retinopathy in Chinese patients with Type 2 diabetes. Diabet Med 2006; 23:643-8. [PMID: 16759306].
31. Petrovic MG, Osredkar J, Saraga-Babic M, Petrovic D. K469E polymorphism of the intracellular adhesion molecule 1 gene is associated with proliferative diabetic retinopathy in Caucasians with type 2 diabetes. Clin Experiment Ophthalmol 2008; 36:468-72. [PMID: 18942221].
32. Penn JS, Madan A, Caldwell RB, Bartoli M, Caldwell RW, Hartnett ME. Vascular endothelial growth factor in eye disease. Prog Retin Eye Res 2008; 27:331-71. [PMID: 18653375].
33. Rahimi N. Vascular endothelial growth factor receptors: molecular mechanisms of activation and therapeutic potentials. Exp Eye Res 2006; 83:1005-16. [PMID: 16713597].
34. Gilbert RE, Vranes D, Berka JL, Kelly DJ, Cox A, Wu LL, Stacker SA, Cooper ME. Vascular endothelial growth factor and its receptors in control and diabetic rat eyes. Lab Invest 1998; 78:1017-27. [PMID: 9714188].
35. Chou E, Suzuma I, Way KJ, Opland D, Clermont AC, Naruse K, Suzuma K, Bowling NL, Vlahos CJ, Aiello LP, King GL. Decreased cardiac expression of vascular endothelial growth factor and its receptors in insulin-resistant and diabetic States: a possible explanation for impaired collateral formation in cardiac tissue. Circulation 2002; 105:373-9. [PMID: 11804995].
36. Ishida S, Shinoda K, Kawashima S, Oguchi Y, Okada Y, Ikeda E. Coexpression of VEGF receptors VEGF-R2 and neuropilin-1 in proliferative diabetic retinopathy. Invest Ophthalmol Vis Sci 2000; 41:1649-56. [PMID: 10845581].
37. Witmer AN, Blaauwgeers HG, Weich HA, Alitalo K, Vrensen GF, Schlingemann RO. Altered expression patterns of VEGF receptors in human diabetic retina and in experimental VEGF-induced retinopathy in monkey. Invest Ophthalmol Vis Sci 2002; 43:849-57. [PMID: 11867607].
38. Huang H, Shen J, Vinores SA. Blockade of VEGFR1 and 2 suppresses pathological angiogenesis and vascular leakage in the eye. PLoS ONE 2011; 6:e21411-[PMID: 21731737].
39. Försti A, Jin Q, Altieri A, Johansson R, Wagner K, Enquist K, Grzybowska E, Pamula J, Pekala W, Hallmans G, Lenner P, Hemminki K. Polymorphisms in the KDR and POSTN genes: association with breast cancer susceptibility and prognosis. Breast Cancer Res Treat 2007; 101:83-93. [PMID: 16807673].
40. Kariyazono H, Ohno T, Khajoee V, Ihara K, Kusuhara K, Kinukawa N, Mizuno Y, Hara T. Association of vascular endothelial growth factor (VEGF) and VEGF receptor gene polymorphisms with coronary artery lesions of Kawasaki disease. Pediatr Res 2004; 56:953-9. [PMID: 15470196].
41. Wang Y, Zheng Y, Zhang W, Yu H, Lou K, Zhang Y, Qin Q, Zhao B, Yang Y, Hui R. Polymorphisms of KDR gene are associated with coronary heart disease. J Am Coll Cardiol 2007; 50:760-7. [PMID: 17707181].
42. Abouammoh M, Sharma S. Ranibizumab versus bevacizumab for the treatment of neovascular age-related macular degeneration. Curr Opin Ophthalmol 2011; 22:152-8. [PMID: 21483262].
43. Ozturk BT, Kerimoglu H, Bozkurt B, Okudan S. Comparison of intravitreal bevacizumab and ranibizumab treatment for diabetic macular edema. J Ocul Pharmacol Ther 2011; 27:373-7. [PMID: 21631366].
44. Abhary S, Burdon KP, Gupta A, Lake S, Selva D, Petrovsky N, Craig JE. Common Sequence Variation in the VEGFA Gene Predicts Risk of Diabetic Retinopathy. Invest Ophthalmol Vis Sci 2009; 50:5552-8. [PMID: 19553626].
45. Churchill AJ, Carter JG, Lovell HC, Ramsden C, Turner SJ, Yeung A, Escardo J, Atan D. VEGF polymorphisms are associated with neovascular age-related macular degeneration. Hum Mol Genet 2006; 15:2955-61. [PMID: 16940309].
46. Liew G, Klein R, Wong TY. The role of genetics in susceptibility to diabetic retinopathy. Int Ophthalmol Clin 2009; 49:35-52. [PMID: 19349785].